ID

44020

Beschrijving

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00049998

Link

https://clinicaltrials.gov/show/NCT00049998

Trefwoorden

Versies (2)
  1. 25-05-16 25-05-16 -
  2. 20-09-21 20-09-21 -
Geüploaded op

20 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Non-Small-Cell Lung Cancer NCT00049998

Engels

Eligibility Non-Small-Cell Lung Cancer NCT00049998

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Beschrijving

written informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
patients with advanced non-small cell lung cancer (nsclc).
Beschrijving

nsclc

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
patients who have received one previous chemotherapy for nsclc.
Beschrijving

previous chemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
full recovery from previous chemotherapy.
Beschrijving

full recovery from previous chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C2004454
UMLS CUI [1,2]
C0392920
presence of either measurable or non-measurable disease by radiologic study or physical examination.
Beschrijving

comorbidity

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
at least 3 weeks since last major surgery (a lesser period is acceptable if deemed in the best interest of the patient).
Beschrijving

major surgery

Datatype

boolean

Alias
UMLS CUI [1]
C0679637
at least 24 hours since prior radiotherapy providing that marked bone marrow suppression is not expected. patients who have received radiotherapy must have recovered from any reversible side effects (e.g. nausea and vomiting).
Beschrijving

recovered from any reversible side effects

Datatype

boolean

Alias
UMLS CUI [1,1]
C2826210
UMLS CUI [1,2]
C0001688
UMLS CUI [1,3]
C1522449
laboratory criteria: patients must have adequate bone marrow reserve and adequate kidney and liver function.
Beschrijving

adequate bone marrow reserve and adequate kidney and liver function

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0205411
UMLS CUI [2,1]
C0232804
UMLS CUI [2,2]
C0205411
UMLS CUI [3,1]
C0232741
UMLS CUI [3,2]
C0205411
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
symptoms of brain metastasis (cancer spreading to the brain), requiring treatment with steroids.
Beschrijving

brain metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
active infection.
Beschrijving

active infection

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
severe medical problems other than the diagnosis of nsclc, that would limit the ability of the patient to follow study guidelines or expose the patient to extreme risk.
Beschrijving

comorbidity limiting study participation

Datatype

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of nsclc.
Beschrijving

planned therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1301732
use of investigational drug within 30 days prior to the first dose of study medication.
Beschrijving

participation in another trial

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
women who are pregnant or lactating.
Beschrijving

pregnant or lactating women

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients of child-bearing potential refusing to practice adequate birth control methods.
Beschrijving

contraceptive use

Datatype

boolean

Alias
UMLS CUI [1]
C1999124
patients with conditions which might alter absorption of an oral drug.
Beschrijving

conditions which might alter absorption

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0000854
Terug naar het begin van de pagina

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT00049998

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
nsclc
Item
patients with advanced non-small cell lung cancer (nsclc).
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
previous chemotherapy
Item
patients who have received one previous chemotherapy for nsclc.
boolean
C0392920 (UMLS CUI [1])
full recovery from previous chemotherapy
Item
full recovery from previous chemotherapy.
boolean
C2004454 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
comorbidity
Item
presence of either measurable or non-measurable disease by radiologic study or physical examination.
boolean
C0009488 (UMLS CUI [1])
major surgery
Item
at least 3 weeks since last major surgery (a lesser period is acceptable if deemed in the best interest of the patient).
boolean
C0679637 (UMLS CUI [1])
recovered from any reversible side effects
Item
at least 24 hours since prior radiotherapy providing that marked bone marrow suppression is not expected. patients who have received radiotherapy must have recovered from any reversible side effects (e.g. nausea and vomiting).
boolean
C2826210 (UMLS CUI [1,1])
C0001688 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,3])
adequate bone marrow reserve and adequate kidney and liver function
Item
laboratory criteria: patients must have adequate bone marrow reserve and adequate kidney and liver function.
boolean
C0005953 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C0232741 (UMLS CUI [3,1])
C0205411 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
brain metastasis
Item
symptoms of brain metastasis (cancer spreading to the brain), requiring treatment with steroids.
boolean
C0220650 (UMLS CUI [1])
active infection
Item
active infection.
boolean
C0009450 (UMLS CUI [1])
comorbidity limiting study participation
Item
severe medical problems other than the diagnosis of nsclc, that would limit the ability of the patient to follow study guidelines or expose the patient to extreme risk.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
planned therapy
Item
ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of nsclc.
boolean
C0087111 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
participation in another trial
Item
use of investigational drug within 30 days prior to the first dose of study medication.
boolean
C2348568 (UMLS CUI [1])
pregnant or lactating women
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
contraceptive use
Item
patients of child-bearing potential refusing to practice adequate birth control methods.
boolean
C1999124 (UMLS CUI [1])
conditions which might alter absorption
Item
patients with conditions which might alter absorption of an oral drug.
boolean
C0087111 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0000854 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial